| 1 |
NCT01129401 |
Completed |
Stonewall Treatment Evaluation Project |
- Substance Abuse
- HIV Infections
|
- Behavioral: Stonewall Project
|
Interventional
|
Phase 1
Phase 2 |
- University of California, San Francisco
- California HIV/AIDS Research Program
|
Other |
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- stimulant use (measured via self-report and urine toxicology screening)
- sexual risk taking
|
150 |
Male |
18 Years and older (Adult, Older Adult) |
NCT01129401 |
CR08-SF-423 |
STEP |
March 2010 |
December 2012 |
May 2014 |
May 24, 2010 |
October 27, 2014 |
|
- San Francisco AIDS Foundation
San Francisco, California, United States - University of California, San Francisco
San Francisco, California, United States
|
|
| 2 |
NCT01122186 |
Completed |
Intervention Targeting Medication Adherence and Methamphetamine Use in HIV Positive Men (ACE) |
- HIV Medication Adherence
- Methamphetamine Use
- Sexual Risk
- (and 2 more...)
|
- Behavioral: Motivational Interviewing + Cognitive Behavioral Skills Training
- Behavioral: Education Attention Control
|
Interventional
|
Not Applicable |
- Hunter College of City University of New York
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Adherence to HIV medication
- Methamphetamine use.
- Sexual Risk
- Polysubstance use
|
210 |
Male |
18 Years and older (Adult, Older Adult) |
NCT01122186 |
1R01DA023395 |
ACE |
September 2007 |
January 2012 |
January 2012 |
May 13, 2010 |
June 3, 2013 |
|
- Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY
New York, New York, United States
|
|
| 3 |
NCT01118416 |
Completed |
Risk Reduction Intervention for Vulnerable Young Adult Males |
|
- Behavioral: HIV prevention intervention randomized control trial
|
Interventional
|
Not Applicable |
- Hunter College of City University of New York
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Sexual risk
- motivation to change club drug use and unsafe sex over 12 months
|
317 |
Male |
18 Years to 29 Years (Adult) |
NCT01118416 |
R01DA020366 |
YMHP |
June 2006 |
September 2010 |
October 2011 |
May 6, 2010 |
June 3, 2013 |
|
- Center for HIV/AIDS Educational Studies and Training of Hunter College, CUNY
New York, New York, United States
|
|
| 4 |
NCT01118767 |
Unknown † |
Evaluation of a Computer-Based System Using Cell Phones for HIV People in Peru |
- HIV
- Adherence
- Sexual Behavior
- HIV Infections
|
- Other: Cell phone intervention
|
Interventional
|
Not Applicable |
- Universidad Peruana Cayetano Heredia
- John E. Fogarty International Center (FIC)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Health Services Research
|
- Self-reported medication adherence
- HIV-1 viral load
- CD4
- Self-reported HIV transmission risk behaviors
|
200 |
All |
18 Years and older (Adult, Older Adult) |
NCT01118767 |
R01TW007896 |
Cell-POS |
May 2010 |
December 2011 |
December 2011 |
May 7, 2010 |
June 16, 2010 |
|
- Universidad Peruana Cayetano Heredia
Lima, Peru - Via Libre
Lima, Peru
|
|
| 5 |
NCT01125371 |
Completed |
Computerized Brief Alcohol Intervention (BI) for Binge Drinking HIV At-Risk and Infected Women |
- Alcohol; Harmful Use
- Binge Drinking
- Risk Behavior
- HIV Infection
|
- Behavioral: Computerized brief alcohol intervention + IVR booster calls
- Behavioral: Computerized brief alcohol intervention
- Behavioral: Attention Control
|
Interventional
|
Not Applicable |
- Johns Hopkins University
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: Double (Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
|
439 |
Female |
18 Years to 90 Years (Adult, Older Adult) |
NCT01125371 |
NIAAAGC018632
R01AA018632 |
|
October 2011 |
June 7, 2016 |
June 7, 2016 |
May 18, 2010 |
October 31, 2018 |
|
- Baltimore City Health Department STD Clinic
Baltimore, Maryland, United States
|
|
| 6 |
NCT01121692 |
Completed |
Venue-Based Couples CoOp in South Africa |
|
- Behavioral: Couples Intervention
- Behavioral: Women's CoOp
- Behavioral: Women's CoOp and Men's Intervention
|
Interventional
|
Phase 2 |
- RTI International
- National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- Medical Research Council, South Africa
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Single Group Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Reduced alcohol use
- reduced gender-based violence
|
600 |
All |
18 Years and older (Adult, Older Adult) |
NCT01121692 |
NIAAA-Wechsberg-AA018076
R01AA018076 |
Couples CoOp |
May 2010 |
September 2012 |
September 2012 |
May 12, 2010 |
October 12, 2015 |
|
- Medical Research Council
Cape Town, South Africa
|
|
| 7 |
NCT02330133 |
Completed |
Mid-life Women: Preventing Unintended Pregnancy and STIs |
|
- Behavioral: Women's Reproductive Health
- Behavioral: Online sexual health content
|
Interventional
|
Phase 2 |
- Oregon Center for Applied Science, Inc.
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
|
Industry / NIH |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
|
- Knowledge of reproductive health issues
- Attitudes about reproductive health and prevention
- Self-efficacy for engaging in strategies to prevent pregnancy and communicate with partner about health risks
- Intentions to engage in strategies to prevent pregnancy and communicate with
|
333 |
Female |
25 Years to 55 Years (Adult) |
NCT02330133 |
SBIR64R-2
R44HD044374 |
FemRepro_2 |
May 2008 |
September 2009 |
September 2009 |
January 1, 2015 |
January 1, 2015 |
|
- Oregon Center for Applied Science
Eugene, Oregon, United States
|
|
| 8 |
NCT01117675 |
Completed |
A New Telemedicine Approach for Chronic HIV/AIDS Patient Home Care |
|
- Other: Virtual Hospital
- Other: Standard of Care
|
Interventional
|
Not Applicable |
- Hospital Clinic of Barcelona
- Bioengineering and Telemedicine Unit.Universidad Politécnica de Madrid
|
Other |
- Allocation: Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Supportive Care
|
- Clinical evaluation of patients cared through Virtual Hospital
|
83 |
All |
18 Years and older (Adult, Older Adult) |
NCT01117675 |
Hospital Clinic
Universidad Politecnica Madrid |
|
January 2005 |
December 2007 |
December 2007 |
May 5, 2010 |
May 5, 2010 |
|
- Agata Leon
Barcelona, Spain
|
|
| 9 |
NCT01127204 |
Completed |
Evaluation of Simplified Antiretroviral Treatment Strategies in HIV Infected Children Treated by Antiretroviral (ARV) Before One Year of Age |
|
- Drug: AZT-3TC-LPV/r twice a day
- Drug: ABC-3TC-EFV once a day
|
Interventional
|
Phase 2
Phase 3 |
- French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
- European and Developing Countries Clinical Trials Partnership (EDCTP)
- Public Research Centre Health, Luxembourg
- (and 10 more...)
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Initial therapeutic cohort: Virological success
- Randomised simplification phase: Virological success
- Virological success
- (and 5 more...)
|
161 |
All |
3 Months to 12 Months (Child) |
NCT01127204 |
ANRS 12206 MONOD
IP.2007.33011.002 |
|
June 2011 |
April 2015 |
April 2015 |
May 20, 2010 |
July 12, 2016 |
|
- Service de maladies infectieuses - CHU Charles de Gaulle
Ouagadougou, Burkina Faso - Service de pédiatrie - CHU Yalgado Ouedraogo
Ouagadougou, Burkina Faso - CEPREF
Abidjan, Côte D'Ivoire - FSU abobo-Avocatier
Abidjan, Côte D'Ivoire
|
|
| 10 |
NCT01123915 |
Terminated |
A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People |
|
- Biological: Opal-HIV-Gag(c) Low Dose
- Biological: Opal-HIV-Gag(c) Medium dose
- Biological: Opal-HIV-Gag(c) High dose
- Other: Dimethyl Sulfoxide
|
Interventional
|
Phase 1 |
- Medicines Development Limited
- Phillip T. and Susan M. Ragon Foundation
- Imperial College London
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
- Primary Purpose: Treatment
|
- Safety
- Immunogenicity
- Impact on HIV infection
|
22 |
All |
18 Years to 60 Years (Adult) |
NCT01123915 |
Opal-HIV-1001
2008-005142-23 |
|
May 2010 |
December 2011 |
December 2011 |
May 14, 2010 |
March 22, 2018 |
|
- St Stephen's Centre, Chelsea and Westminster Foundation Trust
London, United Kingdom
|
|
| 11 |
NCT01114425 |
Completed |
Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection |
|
- Drug: raltegravir (Isentress)
- Drug: Truvada®
|
Interventional
|
Phase 3 |
- Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux
- Merck Sharp & Dohme Corp.
|
Other / Industry |
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- To assess the nature and incidence of drug intolerance and to compare the results with those of previous studies conducted according to the same methodology, with other combinations of antiretrovirals.
|
149 |
All |
18 Years and older (Adult, Older Adult) |
NCT01114425 |
382426005_1 |
|
November 1, 2010 |
August 1, 2012 |
December 1, 2012 |
May 3, 2010 |
February 23, 2017 |
|
|
|
| 12 |
NCT01118871 |
Terminated |
The First Failure Study |
|
- Drug: Darunavir, Ritonavir, Truvada
- Drug: Darunavir, Ritonavir and Etravirine
|
Interventional
|
Phase 4 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Mean change from baseline in peripheral and central adipose tissue
- Percentage of patients <50 copies HIV-1 RNA/mL
- Mean change from baseline of absolute CD4+ T cell count
- (and 8 more...)
|
3 |
All |
18 Years and older (Adult, Older Adult) |
NCT01118871 |
FAST1.0 |
FAST |
May 2010 |
May 2013 |
May 2013 |
May 7, 2010 |
March 24, 2015 |
|
- St. Mary's Hospital
London, United Kingdom
|
|
| 13 |
NCT01125228 |
Active, not recruiting |
Effectiveness of Zidovudine vs. Zidovudine Plus Alpha Interferon vs. Interferon for Treatment of HIV |
|
|
Observational
|
|
- National Institute of Allergy and Infectious Diseases (NIAID)
- National Institutes of Health Clinical Center (CC)
|
NIH |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Hospitalizations; AIDS events; Non AIDS events; CD4 and VL; Deaths
|
180 |
All |
18 Years to 99 Years (Adult, Older Adult) |
NCT01125228 |
880172
88-I-0172 |
|
September 15, 1988 |
|
|
May 18, 2010 |
January 15, 2019 |
|
- National Institutes of Health Clinical Center, 9000 Rockville Pike
Bethesda, Maryland, United States
|
|
| 14 |
NCT01116908 |
Completed |
Safe Drinking Water For Households With Infants Born to HIV-Positive Mothers Pilot Study |
|
|
Interventional
|
Not Applicable |
- London School of Hygiene and Tropical Medicine
- University Teaching Hospital, Lusaka, Zambia
- University of Zambia
- Vestergaard Frandsen
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Prevention
|
- Use of LifeStraw Family for children under 2 and all household members
- Microbiological performance of LifeStraw Family
- Impact of LifeStraw Family on longitudinal prevalence of diarrhea
|
120 |
Female |
Child, Adult, Older Adult |
NCT01116908 |
QA270 |
SWIM |
April 2010 |
August 2011 |
August 2011 |
May 5, 2010 |
August 15, 2011 |
|
- Ngwerere Health Clinic and Kasisi Health Clinic
Lusaka, Chongwe District, Lusaka Province, Zambia
|
|
| 15 |
NCT01127464 |
Completed |
DCVax Plus Poly ICLC in Healthy Volunteers |
- HIV-1 Infection
- HIV Infection
- Healthy Volunteers
|
- Drug: DCVax-001
- Drug: Poly-ICLC
- Drug: Placebo
|
Interventional
|
Phase 1 |
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Basic Science
|
- safety and tolerability
- Immunogenicity
|
43 |
All |
18 Years to 60 Years (Adult) |
NCT01127464 |
SSC-0710 |
|
May 2010 |
November 2012 |
November 2012 |
May 20, 2010 |
May 8, 2014 |
|
- Rockefeller University
New York, New York, United States
|
|
| 16 |
NCT01119729 |
Completed |
Cardiovascular Diseases in HIV-infected Subjects (HIV-HEART Study) |
- Detection of Frequency, Severity and Progression of Cardiovascular Diseases in Patients With HIV-infection.
- Effect on Cardiovascular Risk and Life Quality by Age, Gender, Classic Cardiovascular Risk Factors,
- HIV-specific Cardiovascular Risk Factors, Cardiovascular Medication, Antiretroviral Medication
|
|
Observational
|
|
- University Hospital, Essen
- Federal Ministry of Education and Reserach (BMBF)
|
Other |
- Observational Model: Cohort
- Time Perspective: Prospective
|
- Prevalence of cardiovascular diseases
- Prevalence of cardiovascular disorders
|
803 |
All |
18 Years and older (Adult, Older Adult) |
NCT01119729 |
FKZ 01GI0205 |
|
|
|
|
May 10, 2010 |
May 10, 2010 |
|
- Department of Dermatology, University Hospital of Bochum
Bochum, NRW, Germany - HIV Outpatient Department
Dortmund, NRW, Germany - HIV Outpatients Department
Duisburg, NRW, Germany - (and 4 more...)
|
|
| 17 |
NCT01121809 |
Completed |
Plasma and Intracellular Concentrations of Raltegravir and Etravirine Administered Once Daily |
- HIV-1 Infection
- HIV Infections
|
- Drug: Raltegravir
- Drug: Etravirine
|
Interventional
|
Phase 4 |
- Hospitales Universitarios Virgen del Rocío
|
Other |
- Allocation: Non-Randomized
- Intervention Model: Crossover Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Changes in pharmacokinetic parameters (Cmax, Cmin, AUC, t1/2, and Cl), both in plasma and intracellular, of RAL and ETV.
|
16 |
All |
18 Years to 65 Years (Adult, Older Adult) |
NCT01121809 |
LLC-RAET-2009-1
2009-014480-39 |
RAET |
April 2010 |
October 2010 |
January 2011 |
May 12, 2010 |
February 8, 2011 |
|
- Hospitales Universitarios Virgen del Rocio
Sevilla, Spain
|
|
| 18 |
NCT01128920 |
Completed |
Reducing Health Problems Associated With Injection Drug Use |
- Intravenous Drug Abuse
- HIV Infections
|
- Behavioral: Skin and Needle Hygiene Intervention
- Other: No intervention - assessment-only condition
|
Interventional
|
Not Applicable |
- University of Northern Colorado
- University of Colorado, Denver
- Butler Hospital
|
Other |
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: None (Open Label)
- Primary Purpose: Treatment
|
- Reduction in self-reported high-risk injection practices for bacterial infections (as measured through the Bacterial Infections Risk Scale for Injectors)
- Reduction in self-reported high-risk injection practices for HIV/HCV viral infections (as measured through the Risk Assessment Battery)
- Improvement in skin and needle cleaning behavioral skills (as measured through Behavioral Skill Demonstration of Hand/Skin and Needle Cleaning)
- Increase in skin cleaning prior to injection and decrease in subcutaneous/intramuscular injection, as measured through Timeline Followback (TLFB) recall.
|
87 |
All |
18 Years and older (Adult, Older Adult) |
NCT01128920 |
DA026773-01 |
|
June 2009 |
May 2011 |
May 2011 |
May 24, 2010 |
January 4, 2012 |
|
- Project Safe, University of Colorado
Denver, Colorado, United States
|
|
| 19 |
NCT01124591 |
Completed |
Brief Intervention for Drug Misuse in the Emergency Department |
- Substance Abuse Detection
- HIV
- Hepatitis B
- (and 3 more...)
|
- Behavioral: Brief motivational intervention
|
Interventional
|
Phase 2 |
- Rhode Island Hospital
- National Institute on Drug Abuse (NIDA)
|
Other / NIH |
- Allocation: Randomized
- Intervention Model: Factorial Assignment
- Masking: Single (Outcomes Assessor)
- Primary Purpose: Treatment
|
- Reduction in past 30 day drug misuse
- Reduction in behaviors associated with drug misuse
- Reduction negative physical health, psychosocial health, and socioeconomic consequences
- Uptake of HIV and hepatitis B/C screening
|
1030 |
All |
18 Years to 64 Years (Adult) |
NCT01124591 |
0113-09 |
BIDMED |
June 2010 |
December 2014 |
December 2014 |
May 17, 2010 |
June 10, 2015 |
|
- Rhode Island Hospital
Providence, Rhode Island, United States
|
|
Create an RSS feed from your search for:
Download the search results for: